Company intelligence / Profile preview

Beremans

Guildford, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

Beremans was a specialist life sciences consulting firm that provided strategic intelligence and market analysis to the biopharmaceutical industry. The company was well-known for publishing authoritative technical reports on critical drug development topics, including cardiotoxicity, protein misfolding diseases, and vaccine demand forecasting. Led by Dr. Nicholas Miller, Beremans supported biotech and pharmaceutical clients with expert insights into regulatory challenges and competitive landscapes. Although the limited company was officially dissolved in the UK, its research and reports remain widely cited in pharmaceutical literature and patent filings.

Industry: Consulting

Partnerships

Insight Pharma Reports

Beyond the preview

Go deeper on Beremans.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beremans.

Explore the full profile